Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.
Maddy summaryThis bill would allow states to waive certain Affordable Care Act requirements for health insurance starting in 2026, provided they maintain a high-risk insurance pool. Residents in participating states would receive funds directly into "Trump Health Freedom Accounts" instead of traditional premium tax credits, which could be used to purchase health insurance with restrictions on coverage for gender transition procedures and abortion services. The bill also modifies tax credits for small employers in participating states and requires better price transparency and outcomes reporting from healthcare providers. It would directly affect residents and small businesses in states that choose to participate in the waiver program.
Maddy summaryHR 6509, the SAFE Drugs Act of 2025, limits how often pharmacies and healthcare providers can create custom drug formulations that copy standard medications. It restricts compounding any drug essentially identical to a commercially available product to no more than 20 times per month for individual patients. The bill also requires pharmacies compounding such drugs for out-of-state patients more than 20 times monthly to report details to the FDA, while exempting hospital pharmacies. These changes aim to improve safety oversight of non-standard drug compounding by setting clear limits and reporting rules.
Maddy summaryThis bill amends the Natural Gas Act to give the Federal Energy Regulatory Commission (FERC) exclusive authority to approve U.S. LNG export terminal projects, requiring FERC to deem such exports consistent with the public interest. It directly affects natural gas companies seeking to build or expand export facilities and streamlines FERC's review process by removing prior requirements for interagency coordination. The bill clarifies that FERC's decisions won't override existing sanctions laws, including restrictions on trade with countries designated as state sponsors of terrorism under current law. This change aims to accelerate domestic LNG export projects while maintaining legal safeguards for national security and foreign policy.
Maddy summaryHR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.
Maddy summaryThis bill (HR 6469) requires the U.S. State Department, in coordination with the FCC and Treasury, to submit a report within 120 days of enactment assessing internet access options in Iran. The report must evaluate the feasibility of using direct-to-cell wireless technology to expand internet access there, including technical, security, and regulatory considerations. It also analyzes how drone-based systems and signal jamming could affect such technology, surveys Iranian telecom providers (including state ownership and foreign investment), and examines broader implications for communications freedom. The bill does not enact new policy but mandates a government review of potential technological solutions.
Maddy summaryHR 2965, the Small Business Regulatory Reduction Act of 2025, requires the Small Business Administration (SBA) to ensure that the cost to small businesses from federal agency rulemaking (including new rules, modifications, or repeals) does not exceed zero starting in fiscal year 2026. It mandates the SBA’s Office of Advocacy to annually report to Congress on all federal rules affecting small businesses, broken down by the issuing agency. The bill applies to all federal agencies, not just the SBA, and focuses on controlling regulatory costs for small businesses. No new funding is provided to implement these requirements.
Maddy summaryHR 1049 requires public schools receiving federal education funds to disclose information about foreign-funded activities to parents. Schools must provide parents with access to classroom materials or teacher training paid for by foreign governments or entities, and disclose details about foreign donations, contracts, or staff paid with foreign funds upon written request. Parents can request this information within 30 days, and schools must post annual summaries online. The bill aims to increase transparency about foreign influence in K-12 education, directly affecting parents of students in participating schools.
Maddy summaryThe Claiming Age Clarity Act (HR 5284) requires the Social Security Administration to update its official terminology by January 1, 2027. It directs the replacement of specific terms: "early eligibility age" becomes "minimum monthly benefit age," "full retirement age" and "normal retirement age" become "standard monthly benefit age," and "delayed retirement credit" is eliminated, with "maximum monthly benefit age" used instead of age 70 references. This change applies to all Social Security Administration rules, regulations, guidance, and materials, both online and in print, affecting how the agency communicates retirement benefit rules to the public.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
